Silvia Belluti

Via Giuseppe Campi 103
Modena, 41125, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

A Combined Chemoinformatics- and Machine Learning-Based Approach Identifies Chlormidazole as a Drug Repurposing Candidate against Aggressive Prostate Cancer.

A Combined Chemoinformatics- and Machine Learning-Based Approach Identifies Chlormidazole as a Drug Repurposing Candidate against Aggressive Prostate Cancer.

Journal: Journal of medicinal chemistry

Published: December 30, 2025

Targeting monocarboxylate transporter 1 with a copper-chelating coumarin-based bioconjugate: Synthesis and characterization.

Targeting monocarboxylate transporter 1 with a copper-chelating coumarin-based bioconjugate: Synthesis and characterization.

Journal: Journal of inorganic biochemistry

Published: August 04, 2025

Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer.

Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer.

Journal: Journal of medicinal chemistry

Published: July 23, 2025

Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation.

Searching for Novel HDAC6/Hsp90 Dual Inhibitors with Anti-Prostate Cancer Activity: In Silico Screening and In Vitro Evaluation.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: July 25, 2024

Bridging pyrimidine hemicurcumin and Cisplatin: Synthesis, coordination chemistry, and in vitro activity assessment of a novel Pt(II) complex.

Bridging pyrimidine hemicurcumin and Cisplatin: Synthesis, coordination chemistry, and in vitro activity assessment of a novel Pt(II) complex.

Journal: Journal of inorganic biochemistry

Published: June 28, 2024

Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells.

Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells.

Journal: International journal of pharmaceutics

Published: December 01, 2023

Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives.

Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives.

Journal: International journal of molecular sciences

Published: September 14, 2023

Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function.

Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function.

Journal: Cancers

Published: August 16, 2023

Development of Stable Amino-Pyrimidine-Curcumin Analogs: Synthesis, Equilibria in Solution, and Potential Anti-Proliferative Activity.

Development of Stable Amino-Pyrimidine-Curcumin Analogs: Synthesis, Equilibria in Solution, and Potential Anti-Proliferative Activity.

Journal: International journal of molecular sciences

Published: August 07, 2023

Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer.

Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer.

Journal: European journal of medicinal chemistry

Published: June 01, 2023

Corrigendum: Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism.

Corrigendum: Histone deacetylase functions and therapeutic implications for adult skeletal muscle metabolism.

Journal: Frontiers in molecular biosciences

Published: April 07, 2023

The NF-Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer.

The NF-Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer.

Journal: Cancer letters

Published: March 31, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026